Technology firms have doubled their South Florida footprint from 2013 to 2015, according to a new report released by CBRE.
The tech sector accounted for nearly 848,500 square feet in new office leases in 2015, an increase of more than 83 percent from 2014 and more than double the space leased in 2013.
Last year, 3-D software developer Magic Leap signed a lease for 259,737 square feet at the former Motorola Mobility headquarters. And the deal, which marks the biggest lease for the tech sector, is reportedly valued at $542 million.
Even without Magic Leap, office space absorbed by tech firms would have increased by 27 percent year-over-year and by 42 percent compared to 2013, according to the report.
MORE “South Florida’s tech footprint has doubled since 2013: report”
Transdermal Delivery Solutions Corporation (TDSC) www.TDSC.us announced today the receipt of its releases to begin its pivotal phase of clinical trials. The British National Health Service (NHS) Ethics filings (IRAS) and approval of Clinical Trial Applications (CTAs) for TDSC’s Investigational Medical Product Dossier on Hormone Replacement Technologies’ Testagen® HypoSpray® were filed in November, 2015. NHS Ethics reviewed the protocols together on December 16th, 2015 and the Clinical Trial Applications were then finalized in mid-February and filed with the Medicine and Health Products Review Authority’s (MHRA)for their final review and approval, which is provided in the Notices of Acceptance of Amended Request received today.
“We are pleased that NHS Ethics and MHRA have responded so quickly to move us forward towards this next critical milestone. We expect to initiate patient screening within a few weeks,” said Kenneth Kirby, President of TDSC. “As with any drug delivery FDA-approval process, it’s been a long road of regulatory channels over the course of its development, complicated by having to repeat the process in the UK under EMEA protocols as well. It’s an exciting milestone to reach in this final stage of validating the Testagen® Testosterone HypoSpray®, which we expect to out-perform the competition.”
MORE “Transdermal Delivery Solutions Announces Regulatory Approval of Clinical Trials Commencement of Testagen® Topical Testosterone HypoSpray®”
Modernizing Medicine, Inc., the creator of the Electronic Medical Assistant® (EMA™), today revealed modmed EMA for Pain Medicine, a cloud-based, specialty-specific electronic health record (EHR) system. This new pain medicine specific EHR system is coupled with a practice management and revenue cycle management (RCM) for a complete suite designed to improve physician office efficiencies.
Designed and coded by practicing pain medicine physicians, the highly intuitive and adaptable modmed EMA for Pain Medicine is built on the cloud-based, iPad native EMA platform that has proven a physician favorite across eight other supported specialties, including orthopedics. With highly visual tap and touch interfaces and functionality such as the EMA Interactive Anatomical Atlas™, modmed EMA for Pain Medicine is designed to streamline physician workflow and improve patient reporting and outcomes.
With the EMA Interactive Anatomical Atlas, physicians can access and manipulate over 75,000 touch-points on the body and peel back the skin to reveal typical pain-points, including muscles, joints and tendons. The skeleton view in EMA isn’t simply a visual representation of bones; it’s organized into common injury and fracture patterns and helps to automate billing and reporting.
“The beauty of modmed EMA for Pain Medicine is that it is designed and coded by real pain medicine physicians that understand the unique challenges of the specialty,” said Dr. Elana M. Oberstein, Senior Medical Director of Musculoskeletal at Modernizing Medicine. “Not only does the system remember physician preferences for particular diagnoses and procedures, the Protocols feature lets users create master visits for frequently encountered conditions. These user designed protocols can then be applied to exams like routine visits, new patient exams and pre- and post-procedural instruction.”
MORE “MODERNIZING MEDICINE UNVEILS MODMED EMA™ FOR PAIN MEDICINE AT AMERICAN SOCIETY OF INTERVENTIONAL PAIN PHYSICIANS (ASIPP)”